Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches

Front Cell Infect Microbiol. 2024 Oct 17:14:1497018. doi: 10.3389/fcimb.2024.1497018. eCollection 2024.

Authors

Clement Meseko¹, Melvin Sanicas², Yash Gupta³, Binod Kumar⁴

Affiliations

¹ Regional Centre for Animal Influenza, National Veterinary Research Institute, Vom, Nigeria.
² Medical and Clinical Development, Clover Biopharmaceuticals, Boston, MA, United States.
³ Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, United States.
⁴ Department of Antiviral Research, Institute of Advanced Virology, Thiruvananthapuram, Kerala, India.

No abstract available

Keywords: COVID-19; SARS-CoV2; antiviral drugs; cellular signaling; coronavirus; herpesvirus; influenza virus; vaccines.

Publication types

Editorial